Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2012 1
2013 4
2014 8
2015 4
2016 4
2017 1
2019 1
2020 2
2021 1
2022 3
2023 7
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials.
Heier JS, Lad EM, Holz FG, Rosenfeld PJ, Guymer RH, Boyer D, Grossi F, Baumal CR, Korobelnik JF, Slakter JS, Waheed NK, Metlapally R, Pearce I, Steinle N, Francone AA, Hu A, Lally DR, Deschatelets P, Francois C, Bliss C, Staurenghi G, Monés J, Singh RP, Ribeiro R, Wykoff CC; OAKS and DERBY study investigators. Heier JS, et al. Among authors: lally dr. Lancet. 2023 Oct 21;402(10411):1434-1448. doi: 10.1016/S0140-6736(23)01520-9. Lancet. 2023. PMID: 37865470 Clinical Trial.
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial.
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Monés J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ; GATHER2 trial investigators. Khanani AM, et al. Among authors: lally dr. Lancet. 2023 Oct 21;402(10411):1449-1458. doi: 10.1016/S0140-6736(23)01583-0. Epub 2023 Sep 8. Lancet. 2023. PMID: 37696275
Oculocutaneous albinism.
Goldberg RA, Lally DR, Heier JS. Goldberg RA, et al. Among authors: lally dr. JAMA Ophthalmol. 2015 Mar;133(3):e143518. doi: 10.1001/jamaophthalmol.2014.3518. Epub 2015 Mar 12. JAMA Ophthalmol. 2015. PMID: 25763554 No abstract available.
Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.
Danzig CJ, Khanani AM, Kaiser PK, Chang MA, Kovach JL, Lally DR, Rachitskaya A, Sheth VS, Vajzovic L, Clark J, Tang J, Zhu L, Desai D, Chakravarthy U. Danzig CJ, et al. Among authors: lally dr. Ophthalmol Retina. 2024 Nov;8(11):1052-1060. doi: 10.1016/j.oret.2024.04.023. Epub 2024 May 7. Ophthalmol Retina. 2024. PMID: 38719191 Free article. Clinical Trial.
Choroidal Effusions Secondary to Carotid Cavernous Fistula.
Sheng J, Lally DR, Shah CP. Sheng J, et al. Among authors: lally dr. Ophthalmol Retina. 2017 May-Jun;1(3):226. doi: 10.1016/j.oret.2016.11.009. Epub 2017 May 1. Ophthalmol Retina. 2017. PMID: 31047425 No abstract available.
Natural history of Valsalva-induced subhyaloid hemorrhage.
Szelog JT, Lally DR, Heier JS. Szelog JT, et al. Among authors: lally dr. JAMA Ophthalmol. 2015 Feb;133(2):e143268. doi: 10.1001/jamaophthalmol.2014.3268. Epub 2015 Feb 12. JAMA Ophthalmol. 2015. PMID: 25674894 No abstract available.
Screen Failures in Clinical Trials in Retina.
Hasan N, Mehrotra K, Danzig CJ, Eichenbaum DA, Ewald A, Regillo C, Momenaei B, Sheth VS, Lally DR, Chhablani J. Hasan N, et al. Among authors: lally dr. Ophthalmol Retina. 2024 Nov;8(11):1093-1099. doi: 10.1016/j.oret.2024.05.014. Epub 2024 May 27. Ophthalmol Retina. 2024. PMID: 38810882
39 results